F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC – Get Free Report)’s share price rose 0.1% during mid-day trading on Thursday . The company traded as high as $40.10 and last traded at $36.4890. Approximately 65,385 shares changed hands during trading, an increase of 1,091% from the average daily volume of 5,490 shares. The stock had previously closed at $36.45.
F/m Emerald Life Sciences Innovation ETF Trading Down 0.1%
The firm has a fifty day moving average price of $36.68 and a 200 day moving average price of $32.98.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in F/m Emerald Life Sciences Innovation ETF stock. Hunter Associates Investment Management LLC increased its position in shares of F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC – Free Report) by 13.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 45,908 shares of the company’s stock after acquiring an additional 5,312 shares during the quarter. Hunter Associates Investment Management LLC owned 1.81% of F/m Emerald Life Sciences Innovation ETF worth $1,684,000 as of its most recent SEC filing.
F/m Emerald Life Sciences Innovation ETF Company Profile
The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.
Featured Articles
- Five stocks we like better than F/m Emerald Life Sciences Innovation ETF
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- Unlocked: Elon Musk’s Next Big IPO
Receive News & Ratings for F/m Emerald Life Sciences Innovation ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for F/m Emerald Life Sciences Innovation ETF and related companies with MarketBeat.com's FREE daily email newsletter.
